227 related articles for article (PubMed ID: 32910017)
21. FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary.
Nolan A; Joseph NM; Sangoi AR; Rabban J; Zaloudek C; Garg K
Int J Gynecol Pathol; 2017 Nov; 36(6):568-574. PubMed ID: 28319575
[TBL] [Abstract][Full Text] [Related]
22. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
[TBL] [Abstract][Full Text] [Related]
23. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
[TBL] [Abstract][Full Text] [Related]
24. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
[No Abstract] [Full Text] [Related]
25. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary.
D'Angelo E; Mozos A; Nakayama D; Espinosa I; Catasus L; Muñoz J; Prat J
Mod Pathol; 2011 Oct; 24(10):1360-7. PubMed ID: 21623383
[TBL] [Abstract][Full Text] [Related]
26. Juvenile Granulosa Cell Tumor with an Unusual Clinical Course: A Late-onset and Late Recurrent Case.
San TH; Ota Y; Fushimi S; Fujisawa M; Yanai H; Toda H; Kunitomo T; Kodama K; Matsukawa A
Acta Med Okayama; 2020 Apr; 74(2):159-163. PubMed ID: 32341591
[TBL] [Abstract][Full Text] [Related]
27. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
[TBL] [Abstract][Full Text] [Related]
28. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame
Apellaniz-Ruiz M; de Kock L; Sabbaghian N; Guaraldi F; Ghizzoni L; Beccuti G; Foulkes WD
Eur J Endocrinol; 2018 Feb; 178(2):K11-K19. PubMed ID: 29187512
[TBL] [Abstract][Full Text] [Related]
29. DICER1 hotspot mutations in non-epithelial gonadal tumours.
Witkowski L; Mattina J; Schönberger S; Murray MJ; Choong CS; Huntsman DG; Reis-Filho JS; McCluggage WG; Nicholson JC; Coleman N; Calaminus G; Schneider DT; Arseneau J; Stewart CJ; Foulkes WD
Br J Cancer; 2013 Nov; 109(10):2744-50. PubMed ID: 24136150
[TBL] [Abstract][Full Text] [Related]
30. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
31. DICER1-associated Tumors in the Female Genital Tract: Molecular Basis, Clinicopathologic Features, and Differential Diagnosis.
Han LM; Weiel JJ; Longacre TA; Folkins AK
Adv Anat Pathol; 2022 Sep; 29(5):297-308. PubMed ID: 35778792
[TBL] [Abstract][Full Text] [Related]
32. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
Buza N; Wong S; Hui P
Int J Gynecol Pathol; 2018 Jul; 37(4):305-315. PubMed ID: 28700438
[TBL] [Abstract][Full Text] [Related]
33. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Clin Lab Med; 2023 Jun; 43(2):245-274. PubMed ID: 37169445
[TBL] [Abstract][Full Text] [Related]
34. Update on Ovarian Sex Cord-Stromal Tumors.
Ordulu Z
Surg Pathol Clin; 2022 Jun; 15(2):235-258. PubMed ID: 35715160
[TBL] [Abstract][Full Text] [Related]
35. Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads.
Auguste A; Bessière L; Todeschini AL; Caburet S; Sarnacki S; Prat J; D'angelo E; De La Grange P; Ariste O; Lemoine F; Legois B; Sultan C; Zider A; Galmiche L; Kalfa N; Veitia RA
Hum Mol Genet; 2015 Dec; 24(23):6687-98. PubMed ID: 26362254
[TBL] [Abstract][Full Text] [Related]
36. Ovarian sex cord-stromal tumours: an update in recent molecular advances.
Lim D; Oliva E
Pathology; 2018 Feb; 50(2):178-189. PubMed ID: 29275930
[TBL] [Abstract][Full Text] [Related]
37. Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry.
Schultz KA; Harris A; Messinger Y; Sencer S; Baldinger S; Dehner LP; Hill DA
Fam Cancer; 2016 Jan; 15(1):105-10. PubMed ID: 26289771
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.
Wu MK; Vujanic GM; Fahiminiya S; Watanabe N; Thorner PS; O'Sullivan MJ; Fabian MR; Foulkes WD
Mod Pathol; 2018 Jan; 31(1):169-178. PubMed ID: 28862265
[TBL] [Abstract][Full Text] [Related]
39. Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary.
Meurgey A; Descotes F; Mery-Lamarche E; Devouassoux-Shisheboran M
Virchows Arch; 2017 Feb; 470(2):225-229. PubMed ID: 27830327
[TBL] [Abstract][Full Text] [Related]
40. Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis.
Apellaniz-Ruiz M; Sabbaghian N; Chong AL; de Kock L; Cetinkaya S; Bayramoğlu E; Dinjens WNM; McCluggage WG; Wagner A; Yilmaz AA; Foulkes WD
Fam Cancer; 2023 Oct; 22(4):487-493. PubMed ID: 37248399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]